Impact of a flattening filter free linear accelerator on structural shielding design.

PURPOSE The present study aimed to assess the effects of a flattening filter free medical accelerator on structural shielding demands of a treatment vault of a medical linear accelerator. We tried to answer the question, to what extent the required thickness of the shielding barriers can be reduced if instead of the standard flattened photon beams unflattened ones are used. MATERIAL AND METHODS We chose both an experimental as well as a theoretical approach. On the one hand we measured photon dose rates at protected places outside the treatment room and compared the obtained results for flattened and unflattened beams. On the other hand we complied with international guidelines for adequate treatment vault design and calculated the shielding barriers according to the therein given specifications. Measurements were performed with an Elekta Precise™ linac providing nominal photon energies of 6 and 10 MV. This machine underwent already earlier some modifications in order to be able to operate both with and without a flattening filter. Photon dose rates were measured with a LB133-1 dose rate meter manufactured by Berthold. To calculate the thickness of shielding barriers we referred to the Austrian standard ÖNORM S 5216 and to the US American NCRP Report No. 151. RESULTS We determined a substantial photon dose rate reduction for all measurement points and photon energies. For unflattened 6 MV beams a reduction factor ranging from 1.4 to 1.8 was identified. The corresponding values for unflattened 10 MV beams were 2.1 and 3.2. The performed shielding calculations indicated the same tendency: For all relevant radiation components we found a reduction in shielding thickness when unflattened beams were used. The required thickness of primary barriers was reduced up to 8.0%, the thickness of secondary barriers up to 11.4%, respectively. CONCLUSIONS For an adequate dimensioning of treatment vault shielding barriers it is by no means irrelevant if the accommodated linac operates with or without a flattening filter. The lower consumption of shielding space and material for new treatment vaults housing a FFF machine may reduce building costs, whereas for existing vaults one might benefit in terms of increased weekly workload. Also a more frequent use of monitor unit intense treatment techniques as well as aiming at reduced occupational exposure for staff is conceivable.

[1]  D W O Rogers,et al.  Relationship between %dd(10)x and stopping-power ratios for flattening filter free accelerators: a Monte Carlo study. , 2008, Medical physics.

[2]  Radhe Mohan,et al.  Dosimetric properties of photon beams from a flattening filter free clinical accelerator , 2005, Physics in medicine and biology.

[3]  Radhe Mohan,et al.  Treatment vault shielding for a flattening filter-free medical linear accelerator , 2009, Physics in medicine and biology.

[4]  Dietmar Georg,et al.  Radiation therapy with unflattened photon beams: dosimetric accuracy of advanced dose calculation algorithms. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  Jan Hrbacek,et al.  Commissioning of photon beams of a flattening filter-free linear accelerator and the accuracy of beam modeling using an anisotropic analytical algorithm. , 2011, International journal of radiation oncology, biology, physics.

[6]  Yvonne Dzierma,et al.  Beam properties and stability of a flattening-filter free 7 MV beam-an overview. , 2012, Medical physics.

[7]  Robert Jeraj,et al.  Radiation characteristics of helical tomotherapy. , 2004, Medical physics.

[8]  Pietro Mancosu,et al.  Pretreatment quality assurance of flattening filter free beams on 224 patients for intensity modulated plans: a multicentric study. , 2012, Medical physics.

[9]  Tommy Knöös,et al.  Dosimetric characteristics of 6 and 10MV unflattened photon beams. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  D. Georg,et al.  Experimental determination of peripheral photon dose components for different IMRT techniques and linear accelerators. , 2009, Zeitschrift fur medizinische Physik.

[11]  Tommy Knöös,et al.  Photon beam quality variations of a flattening filter free linear accelerator. , 2009, Medical physics.

[12]  Max Dahele,et al.  Dosimetric impact of intra-fraction motion during high dose rate stereotactic vertebral radiotherapy using flattened and flattening filter free beams , 2012 .

[13]  D. Low,et al.  Measurement of LINAC 90° head leakage radiation TVL values. , 2006, Medical physics.

[14]  Jason Cashmore,et al.  The characterization of unflattened photon beams from a 6 MV linear accelerator , 2008, Physics in medicine and biology.

[15]  D. Greene,et al.  Central axis depth dose data for use in radiotherapy : a survey of depth doses and related data measured in water or equivalent media , 1972 .

[16]  T Lindmo,et al.  Monte Carlo study of in-field and out-of-field dose distributions from a linear accelerator operating with and without a flattening-filter. , 2012, Medical physics.

[17]  P. Andreo,et al.  Absorbed Dose Determination in External Beam Radiotherapy: An International Code of Practice for Dosimetry based on Standards of Absorbed Dose to Water , 2001 .

[18]  Elinore Wieslander,et al.  A Monte Carlo study of a flattening filter-free linear accelerator verified with measurements , 2010, Physics in medicine and biology.

[19]  Tommy Knöös,et al.  Current status and future perspective of flattening filter free photon beams. , 2011, Medical physics.

[20]  Tommy Knöös,et al.  Flattening filter free beams in SBRT and IMRT: dosimetric assessment of peripheral doses. , 2011, Zeitschrift fur medizinische Physik.

[21]  D. Georg,et al.  Experimental Determination of Peripheral Doses for Different IMRT Techniques Delivered by a Siemens Linear Accelerator , 2008, Strahlentherapie und Onkologie.

[22]  U Titt,et al.  Radiation safety survey on a flattening filter-free medical accelerator. , 2007, Radiation protection dosimetry.